Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Bristol-Myers Squibb selects diacid for development as antipsoriatic

June 4, 1997

ProCyte launches GraftCyte products

May 28, 1997

Dusa reports progress in phase III trial of Levulan PDT

May 23, 1997

VIMRx acquires worldwide rights to wound-healing agent

May 21, 1997

Ointment formulation of BioCryst's BCX-34 enters phase II for psoriasis

May 20, 1997

Safety, pharmacological, phase I and early phase II results for SM-10902

May 20, 1997

CytoMed initiates phase II trials of CMI-392

May 9, 1997

Dermik introduces combination acne therapy in South Africa

May 9, 1997

FDA advisory panel denies approval for Genzyme's Sepracoat

May 8, 1997

Abbott discovers potent topical immunosuppressant with minimal systemic effects

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...